Cite
53 - Spliceosome components and splicing factors as novel therapeutic targets for prostate cancer.
MLA
Jiménez-Vacas, J. M., et al. “53 - Spliceosome Components and Splicing Factors as Novel Therapeutic Targets for Prostate Cancer.” European Urology Supplements, vol. 18, no. 1, Mar. 2019, p. e71. EBSCOhost, https://doi.org/10.1016/S1569-9056(19)30054-5.
APA
Jiménez-Vacas, J. M., Herrero-Aguayo, V., Gómez-Gómez, E., León-González, A. J., Sáez-Martínez, P., Montero-Hidalgo, A. J., González-Serrano, T., Requena-Tapia, M. J., Castaño, J. P., Gahete, M. D., & Luque, R. M. (2019). 53 - Spliceosome components and splicing factors as novel therapeutic targets for prostate cancer. European Urology Supplements, 18(1), e71. https://doi.org/10.1016/S1569-9056(19)30054-5
Chicago
Jiménez-Vacas, J.M., V. Herrero-Aguayo, E. Gómez-Gómez, A.J. León-González, P. Sáez-Martínez, A.J. Montero-Hidalgo, T. González-Serrano, et al. 2019. “53 - Spliceosome Components and Splicing Factors as Novel Therapeutic Targets for Prostate Cancer.” European Urology Supplements 18 (1): e71. doi:10.1016/S1569-9056(19)30054-5.